Breaking News Instant updates and real-time market news.

HSIC

Henry Schein

$62.41

0.56 (0.91%)

11:50
10/16/19
10/16
11:50
10/16/19
11:50

Judge dismisses FTC complaint against Henry Schein

Chief Administrative Law Judge D. Michael Chappell has held that two of three respondents named in a Federal Trade Commission complaint violated U.S. antitrust laws by conspiring to refuse to provide discounts to, or otherwise serve, buying groups representing dental practitioners. The FTC's February 2018 administrative complaint named the nation's three largest dental supply companies: Benco Dental Supply Company, Henry Schein (HSIC), and Patterson Companies. As full-service dental distributors, these companies offer gloves, cements, sterilization products and a range of other consumable supplies, as well as equipment, such as dental chairs and lights. Collectively, the big three control more than 85 percent of all distributor sales of dental products and services nationwide. The U.S. market for dental products is valued at approximately $10B. Judge Chappell held that Benco and Patterson were part of the conspiracy, but Schein was not. Judge Chappell added that the evidence fails to prove a conspiracy involving Schein, and dismissed the complaint against Schein. Reference Link

  • 08

    Nov

  • 12

    Dec

HSIC Henry Schein
$62.41

0.56 (0.91%)

05/15/19
05/15/19
DOWNGRADE
Target $70

Market Perform
Henry Schein downgraded to Market Perform on valuation at SVB Leerink
As previously reported, SVB Leerink analyst David Larsen downgraded Henry Schein to Market Perform from Outperform and lowered his price target on the shares to $70 from $75. While the analyst acknowledges that he still likes the company and believes its end-markets remain healthy, he notes that the stock has appreciated considerably and at current levels, he believes Henry Schein is fairly valued. Additionally, Larsen thinks the company may face more pressure from online retailers.
05/30/19
WOLF
05/30/19
INITIATION
Target $69
WOLF
Underperform
Henry Schein initiated with an Underperform at Wolfe Research
Wolfe Research initiated Henry Schein with an Underperform and $69 price target.
08/07/19
WBLR
08/07/19
DOWNGRADE
WBLR
Market Perform
Henry Schein downgraded to Market Perform from Outperform at William Blair
William Blair analyst John Kreger downgraded Henry Schein to Market Perform from Outperform following the company's Q2 results. The analyst believes the Henry Schein's macro environment remains challenging.
10/07/19
GUGG
10/07/19
DOWNGRADE
Target $200
GUGG
Neutral
Guggenheim downgrades Align Technology on rising competition, sinking sentiment
As previously reported, Guggenheim analyst Glen Santangelo downgraded Align Technology (ALGN) to Neutral from Buy with a price target of $200, down from $250. Santangelo now believes that competition is more aggressive than he originally anticipated after his proprietary channel checks suggested that the technical and service capabilities of the competition, while still "not nearly as good" as Align, may be evolving faster than expected. Many of the established dental companies - such as Dentsply Sirona (XRAY), 3M (MMM), Envista (NVST) and Henry Schein (HSIC) - are offering clear aligners at discounted prices and making a big push in this area, while the direct-to-consumer model has attracted significant attention in the wake of the recent SmileDirectClub (SDC) IPO, Santangelo stated. In all, his view is that sentiment on Align will likely remain challenged until investors fully understand the impact of the new competitive landscape, which may take until later in 2020.

TODAY'S FREE FLY STORIES

HES

Hess Corp.

$71.79

-1.05 (-1.44%)

16:51
11/12/19
11/12
16:51
11/12/19
16:51
Initiation
Hess Corp. initiated  »

Hess Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCON

Tracon Pharmaceuticals

$3.46

-0.48 (-12.18%)

16:51
11/12/19
11/12
16:51
11/12/19
16:51
Syndicate
Breaking Syndicate news story on Tracon Pharmaceuticals »

Tracon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPRT

Oportun Financial

$18.72

0.54 (2.97%)

16:50
11/12/19
11/12
16:50
11/12/19
16:50
Earnings
Oportun Financial sees Q4 EPS 61c-65c, consensus 62c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ESTA

Establishment Labs

$23.60

-0.39 (-1.63%)

16:50
11/12/19
11/12
16:50
11/12/19
16:50
Syndicate
Breaking Syndicate news story on Establishment Labs »

Establishment Labs files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

SE

Sea Limited

$36.78

5.81 (18.76%)

16:49
11/12/19
11/12
16:49
11/12/19
16:49
Syndicate
Breaking Syndicate news story on Sea Limited »

Sea Limited files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

GEVO

Gevo

$2.57

0.065 (2.59%)

16:49
11/12/19
11/12
16:49
11/12/19
16:49
Earnings
Gevo reports Q3 EPS (66c), one estimate (55c) »

Reports Q3 revenue $6.1M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

WMT

Walmart

$119.13

0.1 (0.08%)

16:48
11/12/19
11/12
16:48
11/12/19
16:48
Recommendations
Walmart analyst commentary  »

Baird senses 'upward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

LJPC

La Jolla

$6.70

-0.07 (-1.03%)

16:48
11/12/19
11/12
16:48
11/12/19
16:48
Earnings
La Jolla reports Q3 EPS ($1.08), consensus ($1.08) »

Reports Q3 revenue $5.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OPRT

Oportun Financial

$18.72

0.54 (2.97%)

16:48
11/12/19
11/12
16:48
11/12/19
16:48
Earnings
Oportun Financial reports Q3 EPS 64c, consensus 44c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FCPT

Four Corners Property Trust

$26.95

-0.16 (-0.59%)

16:48
11/12/19
11/12
16:48
11/12/19
16:48
Syndicate
Breaking Syndicate news story on Four Corners Property Trust »

Four Corners Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$362.89

-4.08 (-1.11%)

16:47
11/12/19
11/12
16:47
11/12/19
16:47
Hot Stocks
Boeing names Conrad Chun VP of Communications for Boeing Commercial Airplanes »

Boeing announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

ADPT

Adaptive Biotechnologies

$28.35

0.01 (0.04%)

16:46
11/12/19
11/12
16:46
11/12/19
16:46
Earnings
Adaptive Biotechnologies reports Q3 EPS (11c), consensus (24c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 07

    Dec

CALA

Calithera Biosciences

$3.15

0.01 (0.32%)

16:46
11/12/19
11/12
16:46
11/12/19
16:46
Earnings
Calithera Biosciences reports Q3 EPS (38c), consensus (45c) »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HII

Huntington Ingalls

$253.94

2.975 (1.19%)

16:46
11/12/19
11/12
16:46
11/12/19
16:46
Hot Stocks
Huntington Ingalls starts fabribation of legend-class cutter Calhoun »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SDC

SmileDirectClub

$11.02

-0.83 (-7.00%)

16:45
11/12/19
11/12
16:45
11/12/19
16:45
Hot Stocks
SmileDirectClub reports Q3 unique aligner shipments of 106,070 »

SmileDirectClub reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SDC

SmileDirectClub

$11.02

-0.83 (-7.00%)

16:44
11/12/19
11/12
16:44
11/12/19
16:44
Hot Stocks
Breaking Hot Stocks news story on SmileDirectClub »

SmileDirectClub shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CDLX

Cardlytics

$39.85

0.17 (0.43%)

16:44
11/12/19
11/12
16:44
11/12/19
16:44
Earnings
Cardlytics raises FY19 revenue view to $196M-$200M from $180M-$190M 

Consensus $190.49M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

RNG

RingCentral

$172.89

2.57 (1.51%)

, AVYA

Avaya

$12.53

0.08 (0.64%)

16:43
11/12/19
11/12
16:43
11/12/19
16:43
Hot Stocks
RingCentral issues 2.17M Class A shares to Avaya »

RingCentral, Inc. (RNG)…

RNG

RingCentral

$172.89

2.57 (1.51%)

AVYA

Avaya

$12.53

0.08 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 09

    Dec

SSTI

ShotSpotter

$20.35

-0.01 (-0.05%)

16:43
11/12/19
11/12
16:43
11/12/19
16:43
Earnings
ShotSpotter guides initial FY20 revenue $48M-$50M, consensus $55.94M »

Management also expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SDC

SmileDirectClub

$11.02

-0.83 (-7.00%)

16:43
11/12/19
11/12
16:43
11/12/19
16:43
Hot Stocks
SmileDirectClub targets long-term marketing, selling expenses 40%-45% of sales »

SmileDirectClub said in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SSTI

ShotSpotter

$20.35

-0.01 (-0.05%)

16:43
11/12/19
11/12
16:43
11/12/19
16:43
Earnings
ShotSpotter cuts FY19 revenue view to $40M-$40.5M from $42M-$44.5M 

Consensus $42.9M.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CDLX

Cardlytics

$39.85

0.17 (0.43%)

16:43
11/12/19
11/12
16:43
11/12/19
16:43
Earnings
Breaking Earnings news story on Cardlytics »

Cardlytics sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

SSTI

ShotSpotter

$20.35

-0.01 (-0.05%)

16:42
11/12/19
11/12
16:42
11/12/19
16:42
Earnings
ShotSpotter reports Q3 EPS 4c, consensus 3c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CDLX

Cardlytics

$39.85

0.17 (0.43%)

16:42
11/12/19
11/12
16:42
11/12/19
16:42
Earnings
Cardlytics reports Q3 EPS 3c, consensus (15c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 09

    Dec

FIXX

Homology Medicines

$11.47

0.1 (0.88%)

16:42
11/12/19
11/12
16:42
11/12/19
16:42
Earnings
Homology Medicines reports Q3 EPS (67c), consensus (50c) »

Reports Q3 revenue $441K,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.